G Kozak-Ribbens
Overview
Explore the profile of G Kozak-Ribbens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roux-Buisson N, Monnier N, Sagui E, Abriat A, Brosset C, Bendahan D, et al.
Br J Anaesth
. 2016 Mar;
116(4):566-8.
PMID: 26994242
No abstract available.
2.
Guis S, Figarella-Branger D, Mattei J, Nicoli F, Le Fur Y, Kozak-Ribbens G, et al.
Arthritis Rheum
. 2006 Jul;
55(4):551-7.
PMID: 16874775
Objective: Statins (3-hydroxymethylglutaryl-coenzyme A reductase inhibitor) are widely used to treat hypercholesterolemia. They are generally well tolerated, but myotoxic effects have been reported and the corresponding mechanisms are still a...
3.
Bendahan D, Mattei J, Guis S, Kozak-Ribbens G, Cozzone P
Rev Neurol (Paris)
. 2006 Apr;
162(4):467-84.
PMID: 16585908
31P MRS and 1H MRI of skeletal muscle have become major new tools allowing a complete non invasive investigation of muscle function both in the clinical setting and in basic...
4.
Bendahan D, Guis S, Monnier N, Kozak-Ribbens G, Lunardi J, Ghattas B, et al.
Acta Anaesthesiol Scand
. 2004 Aug;
48(8):1019-27.
PMID: 15315621
Background: The diagnosis of susceptibility to malignant hyperthermia (MH) is currently performed on muscle biopsies subjected to halothane-caffeine in vitro contracture tests (IVCTs). There is a consensus on our need...
5.
Robinson R, Anetseder M, Brancadoro V, Van Broekhoven C, Carsana A, Censier K, et al.
Eur J Hum Genet
. 2003 Apr;
11(4):342-8.
PMID: 12700608
Malignant hyperthermia (MH) is a condition that manifests in susceptible individuals only on exposure to certain anaesthetic agents. Although genetically heterogeneous, mutations in the RYR1 gene (19q13.1) are associated with...
6.
Guis S, Bendahan D, Kozak-Ribbens G, Figarella-Branger D, Mattei J, Pellissier J, et al.
Arthritis Rheum
. 2003 Apr;
49(2):237-8.
PMID: 12687516
No abstract available.
7.
Bendahan D, Mattei J, Kozak-Ribbens G, Cozzone P
Rev Neurol (Paris)
. 2002 Jun;
158(5 Pt 1):527-40.
PMID: 12072821
P-31 MRS has become in a very short time, a major new tool to explore muscle metabolism for clinical diagnostic purposes, while offering a unique non-invasive way to conduct advanced...
8.
Guis S, Bendahan D, Kozak-Ribbens G, Mattei J, Le Fur Y, Confort-Gouny S, et al.
Arthritis Rheum
. 2002 Mar;
46(3):774-8.
PMID: 11920414
Objective: To investigate muscle function in patients with severe myalgia resulting from fluoroquinolone (FQ) treatment. We used histology, in vitro contracture tests (IVCTs), and (31)P magnetic resonance spectroscopy ((31)P MRS)...
9.
Bendahan D, Kozak-Ribbens G, Confort-Gouny S, Ghattas B, Figarella-Branger D, Aubert M, et al.
Anesth Analg
. 2001 Aug;
93(3):683-9.
PMID: 11524341
Exertional heat stroke (EHS) is usually triggered by strenuous exercise performed under hot and humid environmental conditions. Although the pathogenesis of an EHS episode differs from that of a clinical...
10.
Guis S, Jouglard J, Kozak-Ribbens G, Figarella-Branger D, Vanuxem D, Pellissier J, et al.
J Rheumatol
. 2001 Jun;
28(6):1405-6.
PMID: 11409139
Fluoroquinolones cause myalgia, but this complication is not clearly documented. We describe a patient who developed myalgia and rhabdomyolysis during fluoroquinolone treatment. The patient was a 33-year-old man treated with...